A2
Creatine nitrate
- Product declaration
- Creatine Nitrate (as N03T®): 2500 mg
- Selected studied range
- 1500 to 3000 mg
- Protocol and duration
- per day over 28 days, in the one controlled trial located
- Studied context
- A 2016 randomized, placebo-controlled study (Galvan et al., Journal of the International Society of Sports Nutrition) studied creatine nitrate for acute hemodynamic/blood-marker safety and for chronic effects on training performance (bench press lifting volume, power output) compared with creatine monohydrate and placebo.
- Limitations
- The same study found that only creatine monohydrate produced sustained increases in intramuscular creatine concentration through day 28; the high-dose creatine-nitrate group's initial increase "abated" by the end of the study. The evidence base for creatine nitrate is far smaller and shorter-duration than for monohydrate; long-term safety data comparable to monohydrate's multi-year record does not exist.
Selected evidence: Galvan et al., dose dependent creatine nitrate supplementation, 2016 · Open source
